Matthew Stoll, M.D., Pediatric Rheumatology, has been named to the Spondyloarthritis Research and Treatment Network (SPARTAN) Board of Directors. He will serve a three-year term beginning in May 2019 through May 2022.

Congratulations Dr. Stoll!